Chitosan-based particles as controlled drug delivery systems.
about
Marine Origin Polysaccharides in Drug Delivery Systems.Intraocular pressure changes: an important determinant of the biocompatibility of intravitreous implantsNanoparticles from renewable polymersCurrent progress in gene delivery technology based on chemical methods and nano-carriersVisualization of the penetrative and mucoadhesive properties of chitosan and chitosan-coated liposomes through the rat intestine.Biomaterials approaches to combating oral biofilms and dental disease.Anticancer activity of released doxorubicin from a folate-mediated polyelectrolyte complex.Isolation, characterization and heterologous expression of a novel chitosanase from Janthinobacterium sp. strain 4239Antitumor efficacy of doxorubicin released from crosslinked nanoparticulate chondroitin sulfate/chitosan polyelectrolyte complexes.An alginate-based hybrid system for growth factor delivery in the functional repair of large bone defects.Preparation and characterization of novel polymeric microcapsules for live cell encapsulation and therapy.Recent advances of chitosan nanoparticles as drug carriersNatural extracts into chitosan nanocarriers for rosmarinic acid drug delivery.Hexanoyl-Chitosan-PEG Copolymer Coated Iron Oxide Nanoparticles for Hydrophobic Drug Delivery.Nanoparticles and nanofibers for topical drug delivery.Understanding the adsorption mechanism of chitosan onto poly(lactide-co-glycolide) particles.Review paper: chitosan derivatives as promising materials for controlled drug delivery.Electroformation of giant vesicles from an inverse phase precursorNANOTECHNOLOGY IN THE TREATMENT AND DETECTION OF INTRAOCULAR CANCERS.Chitosan as a barrier membrane material in periodontal tissue regeneration.Chitosan nanoparticles: a survey of preparation methods.Chitosan-based gastroretentive floating drug delivery technology: an updated review.Polysaccharides and their derivatives for versatile tissue engineering application.Helicobacter pylori infection: A brief overview on alternative natural treatments to conventional therapy.Recent achievements in colorectal cancer diagnostic and therapy by the use of nanoparticles.5-Fluorouracil enteric-coated nanoparticles for improved apoptotic activity and therapeutic index in treating colorectal cancer.Curcumin-loaded polymeric nanoparticles for enhanced anti-colorectal cancer applications.In vitro efficacy of polysaccharide-based nanoparticles containing disease-modifying antirheumatic drugs.Polysaccharide-based Nanoparticles for Gene Delivery.Chitosan nanocomposites based on distinct inorganic fillers for biomedical applications.Comparative studies on chitosan and polylactic-co-glycolic acid incorporated nanoparticles of low molecular weight heparin.Development of hydrogels and biomimetic regulators as tissue engineering scaffolds.Preparation of chitosan-polyaspartic acid-5-fluorouracil nanoparticles and its anti-carcinoma effect on tumor growth in nude mice.Sustained release of TGFbeta3 from PLGA microspheres and its effect on early osteogenic differentiation of human mesenchymal stem cellsCell-protection mechanism through autophagy in HGFs/S. mitis co-culture treated with Chitlac-nAg.Bone Regeneration Using Bone Morphogenetic Proteins and Various Biomaterial Carriers.Design and in vitro evaluation of a new nano-microparticulate system for enhanced aqueous-phase solubility of curcumin.Preparation, in vitro characterization, pharmacokinetic, and pharmacodynamic evaluation of chitosan-based plumbagin microspheres in mice bearing B16F1 melanoma.Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation.A novel method to prepare magnetite chitosan microspheres conjugated with methotrexate (MTX) for the controlled release of MTX as a magnetic targeting drug delivery system.
P2860
Q26767227-7D514EBD-D24D-49D0-A2A5-260CDB654729Q28478420-A6F9B4CA-2A6F-4B05-B3BA-67474241E836Q28655569-49699CBF-846A-4523-B843-D7CD62E86669Q28659480-5AEFDBC8-98E8-462F-8A5F-C4B2A768F564Q33245789-D12C7F34-6E8D-4E88-AFE2-BCB14CEB68CEQ33255355-0C5E938C-788C-4143-81CA-18E6338CA379Q33631805-433836DB-5B7F-438C-9BD9-BCD25CD2EE19Q33715800-84903489-887A-4685-82D6-521FA20AD9DBQ33832548-088BE47E-3E8C-4E39-989D-DCF162228163Q34454478-73575E2B-8515-4F7A-AC09-785592EB8540Q34615317-A0321C28-BC32-4EFD-9374-43FDA160B283Q34956317-F1A86232-7781-4AD0-9C5E-FB385BBCC86EQ35502502-D5293F75-B57B-4753-995E-FB2E46D5FC4AQ36584869-92932B1D-BEDC-4A18-AFAC-07A4BE23A9A3Q36978587-F12CCC1C-08A9-4901-9D0F-EE8E3004E84DQ37033697-0303D4D0-D00A-4F01-90FD-067D9B709D2BQ37204537-59731B89-997D-472E-A0A0-6FF5B12DD0A8Q37263158-71506228-0717-4FC4-AC1C-876107BC0A89Q37776418-575C3704-B64D-44C8-B09F-170A6451D31CQ37979767-799DEA2C-648F-4123-9EE8-A9823C73083FQ37980520-AD307418-DBD4-4726-87C7-8CABEA8D8FF0Q37996585-43D76733-C286-4A3B-8D6E-6FEDC7B6706DQ38091342-D5723FC1-F6A4-470B-8148-E4EBC31A5C25Q38194189-B10797A1-DF5E-4A0B-A00E-F09602E76A84Q38717321-F45842F2-DC67-457E-8B62-F848A9763682Q38814533-50318629-2631-4C9B-9605-3199AEFB62FFQ38853458-D8F2062B-067B-4FC0-A41F-35F14EB5F561Q39018542-33031B4D-8B40-4438-9225-9AC2F29D2911Q39157625-111EB4E1-969D-4666-8E14-A95A434DE81AQ39161092-689CA432-9D4A-497F-9C24-F3157AF415B4Q39261905-B4F3EFE8-3DDE-4BC7-9FEA-9402633392DFQ39636970-7CD00407-F96B-49B2-B05B-E3688C507E0EQ39970170-FA1C88C7-B550-4ABB-B2C3-8E8E8ED19EA0Q39971441-DF068F6D-40EC-4204-A599-D56B546C73C0Q40481843-64DF8B95-6644-47AB-9A5B-E32F0DFD93B6Q40993075-95CB4A5B-E7EB-4B17-80EB-A6EA1F345DF5Q42558465-E917BF19-72E0-4C51-96DD-AC455970D243Q43184625-3607CBF4-B099-4D2E-9D28-B38E5432727DQ43234583-FE66FB5F-6F8E-491E-9F1F-68F2F1FC847DQ44310672-EB5137FE-4654-46A6-BAE1-68778631603C
P2860
Chitosan-based particles as controlled drug delivery systems.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Chitosan-based particles as controlled drug delivery systems.
@ast
Chitosan-based particles as controlled drug delivery systems.
@en
type
label
Chitosan-based particles as controlled drug delivery systems.
@ast
Chitosan-based particles as controlled drug delivery systems.
@en
prefLabel
Chitosan-based particles as controlled drug delivery systems.
@ast
Chitosan-based particles as controlled drug delivery systems.
@en
P2860
P1433
P1476
Chitosan-based particles as controlled drug delivery systems.
@en
P2093
P2860
P356
10.1080/10717540590889781
P407
P50
P577
2005-01-01T00:00:00Z